124 related articles for article (PubMed ID: 16331288)
1. Modulating GABA modulators.
Paronis CA
Br J Pharmacol; 2006 Feb; 147(3):237-8. PubMed ID: 16331288
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
[TBL] [Abstract][Full Text] [Related]
3. Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys.
McMahon LR; France CP
Br J Pharmacol; 2006 Feb; 147(3):260-8. PubMed ID: 16331290
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
5. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
[TBL] [Abstract][Full Text] [Related]
6. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
[TBL] [Abstract][Full Text] [Related]
7. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys.
McMahon LR; Gerak LR; France CP
J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825
[TBL] [Abstract][Full Text] [Related]
8. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
9. Chronic benzodiazepine treatment does not alter interactions between positive GABA(A) modulators and flumazenil or pentylenetetrazole in monkeys.
Gerak LR; France CP
Behav Pharmacol; 2011 Feb; 22(1):49-57. PubMed ID: 21516176
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the discriminative stimulus effects of positive gamma-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam.
Lelas S; Gerak LR; France CP
J Pharmacol Exp Ther; 2000 Sep; 294(3):902-8. PubMed ID: 10945839
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
[TBL] [Abstract][Full Text] [Related]
13. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
14. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
Reynolds DS
Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
[TBL] [Abstract][Full Text] [Related]
15. Relative positioning of diazepam in the benzodiazepine-binding-pocket of GABA receptors.
Tan KR; Baur R; Charon S; Goeldner M; Sigel E
J Neurochem; 2009 Dec; 111(5):1264-73. PubMed ID: 19804380
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of type A GABA receptors by L-type calcium channel blockers.
Das P; Bell-Horner CL; Huang RQ; Raut A; Gonzales EB; Chen ZL; Covey DF; Dillon GH
Neuroscience; 2004; 124(1):195-206. PubMed ID: 14960351
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test.
Mathiasen LS; Rodgers RJ; Mirza NR
Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483
[TBL] [Abstract][Full Text] [Related]
20. Neuroactive steroid actions at the GABAA receptor.
Lan NC; Gee KW
Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
